Natco v Novartis 2024: Delhi High Court’s Novartis Moment & Indian Patent Law’s Déjà Vu The Delhi High Court, on 24th April, passed an order that our patent law enthusiast readers will be very interested in! Reviving, (and at least temporarily settling!) questions around what is therapeutic efficacy under Section 3(d) and the distinctions between coverage and disclosure, the 86 page judgement is an interesting one to go through! We’re pleased to bring you this guest post by Shivam Kaushik, who takes us on a quick tour of the order, highlighting points of particular interest. […]
https://spicyip.com/2024/05/na....tco-v-novartis-2024-